Jincheng Pharmaceuticals: Subsidiary received certificate of registration for injectable erythromycin lactobionate drug.

Jincheng Pharmaceuticals announced that its holding subsidiary, Guangdong Jincheng Jinsu Pharmaceuticals Co., Ltd., recently received the Injection Lactosyl Erythromycin Approval Certificate issued by the National Medical Products Administration. The 0.25g specification is the first in the country to pass the generic drug quality and efficacy consistency evaluation specification and is listed as a national essential medicine.